Long Focus Capital Management’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Long Focus Capital Management’s Portfolio VINC Stock Details VINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-54,938	Closed	-$1.3M	–	112
2023 Q4	$1.3M	Hold	54,938	–	–	0.04%	82
2023 Q3	$1.11M	Hold	54,938	–	–	0.04%	85
2023 Q2	$1.43M	Sell	54,938 -15,810	-22%	-$452K	0.07%	78
2023 Q1	$1.47M	Hold	70,748	–	–	0.08%	79
2022 Q4	$1.44M	Buy	+70,748	New	+$1.33M	0.1%	71
2022 Q3	–	Sell	-49,000	Closed	-$1.41M	–	119
2022 Q2	$1.29M	Buy	49,000 +27,490	+128%	+$1.22M	0.14%	69
2022 Q1	$1.72M	Buy	21,510 +14,500	+207%	+$1.79M	0.22%	64
2021 Q4	$1.43M	Buy	+7,010	New	+$1.75M	0.19%	62

Other funds holding VINC

SRC

Sage Rhino Capital Menlo Park, California $617M AUM 28.74% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

ECM

ExodusPoint Capital Management New York $15.5B AUM 38.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Long Focus Capital Management's VINC Position: Q1 2024 in Review

Long Focus Capital Management sold out of Vincerx Pharma, Inc. Common Stock (VINC) in Q1 2024, closing a stake of 54,938 shares — an estimated $1.3M sold.

Long Focus Capital Management first reported a position in VINC in Q4 2021 and held it in 8 quarters. The position peaked at $1.72M in Q1 2022. 40 funds tracked by Wall St. Rank hold VINC as of Q1 2024.

Long Focus Capital Management reported no remaining Vincerx Pharma, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Long Focus Capital Management sold 54,938 Vincerx Pharma, Inc. Common Stock shares in Q1 2024, an estimated $1.3M.
Long Focus Capital Management first reported a position in Vincerx Pharma, Inc. Common Stock in Q4 2021 and held it in 8 quarters.
Long Focus Capital Management's Vincerx Pharma, Inc. Common Stock position peaked at $1.72M in Q1 2022.
40 funds tracked by Wall St. Rank held Vincerx Pharma, Inc. Common Stock as of Q1 2024.

Based on Long Focus Capital Management's 13F filing for Q1 2024, filed 14 May 2024.